NCT02432053View on ClinicalTrials.gov

A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in India

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Kidney TransplantationLiver Transplantation
Interventions
DRUG

Advagraf

Trial Locations (7)

Unknown

Andhra Pradesh

Bangalore

Chennai

Mumbai

New Delhi

Tamil Nadu

Uttar Pradesh

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY